Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential

Marie Bastin, Fabrizio Andreelli Diabetology-Metabolism Department, Sorbonne Université, ICAN, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, F-75013, FranceCorrespondence: Fabrizio AndreelliDiabetology-Metabolism Depart...

Full description

Bibliographic Details
Main Authors: Bastin M, Andreelli F
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
incretins
type 2 diabetes
co-agonists
GLP-1
GIP
body weight
Online Access:https://www.dovepress.com/dual-gip-glp1-receptor-agonists-in-the-treatment-of-type-2-diabetes-a--peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/dual-gip-glp1-receptor-agonists-in-the-treatment-of-type-2-diabetes-a--peer-reviewed-article-DMSO

Similar Items